Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1774832 | 1.00 | SPHK1 (0.33) | SPHK1 | |
| SCHEMBL5549078 | 1.00 | SPHK1 (0.33) | SPHK1 | |
| SCHEMBL28516296 | 0.87 | SPHK1 (0.33) | SPHK1 | |
| SCHEMBL1776206 | 0.84 | SPHK1 (0.32) | SPHK1 | |
| SCHEMBL23924723 | 0.81 | SPHK1 (0.33) | SPHK1 | |
| SCHEMBL3450844 | 0.81 | SPHK1 (0.33) | SPHK1 | |
| SCHEMBL19733004 | 0.81 | SPHK1 (0.33) | SPHK1 | |
| SCHEMBL25266764 | 0.80 | SPHK1 (0.30) | SPHK1 | |
| SCHEMBL25212359 | 0.80 | SPHK1 (0.30) | SPHK1 | |
| SCHEMBL14496992 | 0.80 | SPHK1 (0.48) | SPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109970764-B | Synthesis method of (S) -1,1,5, 5-tetramethyl dihydro oxazolo [3,4-c ] oxazol-3-one | 上海吉奉生物科技有限公司 | 2021-11-09 | — | — | CN | claimed |
| CN-109970764-B | Synthesis method of (S) -1,1,5, 5-tetramethyl dihydro oxazolo [3,4-c ] oxazol-3-one | 上海吉奉生物科技有限公司 | 2021-11-09 | — | — | CN | disclosed |
| US-7820673-B2 | Urea derivative, process for producing the same, and use | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-10-26 | — | — | US | disclosed |
| US-20070093501-A1 | Urea derivative, process for producing the same, and use | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-04-26 | — | — | US | disclosed |
| EP-1695961-A1 | UREA DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE | Takeda Pharmaceutical Company Limited (JP) | 2006-08-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070093501-A1 | Urea derivative, process for producing the same, and use | F2, URB2, F12 | SPHK1 3531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.